Who is sponsoring NCT05467579?

NCT05467579 is sponsored by University of Genova.

What drugs are being tested in NCT05467579?

Interventions in NCT05467579: Device: orthodontic - mandibular advancement clear aligner.

What condition does NCT05467579 study?

NCT05467579 studies Juvenile Idiopathic Arthritis, Malocclusion, Angle Class II.

Is NCT05467579 still recruiting?

NCT05467579 is currently status unknown. Last updated 20 July 2022.

Last reviewed 2022-07-20 · How we verify

NCT05467579

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Mandibular Advancement Clear Aligner Treatment in Juvenile Idiopathic Arthritis Subjects

Status unknown NA Last updated 20 July 2022

What this trial tests

NA trial testing Device: orthodontic - mandibular advancement clear aligner in Juvenile Idiopathic Arthritis in 50 participants. Status unknown.

Timeline

1 October 2022

Primary endpoint
1 January 2024

1 January 2025

Quick facts

Lead sponsor	University of Genova
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	50
Start date	1 October 2022
Primary completion	1 January 2024
Estimated completion	1 January 2025
Sites	1 location across Italy

Drugs / interventions tested

Device: orthodontic - mandibular advancement clear aligner

Conditions studied

Juvenile Idiopathic Arthritis — all drugs for Juvenile Idiopathic Arthritis →
Malocclusion, Angle Class II — all drugs for Malocclusion, Angle Class II →

Sponsor

University of Genova

Who can join

Adults 8 to 14, any sex, with Juvenile Idiopathic Arthritis or Malocclusion, Angle Class II. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

There is currently no information on how mandibular advancement therapy could influence three-dimensionally the condylar and mandibular morphology in growing patients affected by Juvenile Idiopathic Arthritis (JIA). Therefore, the aim is to assess the three-dimensional morphological mandibular changes produced by the Invisalign® Mandibular Advancement (MA) (Align Technology, San José, CA, USA) in growing subjects affected by juvenile idiopathic arthritis with unilateral and bilateral JIA and to compare them with not-JIA control subjects

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Juvenile Idiopathic Arthritis

Currently open trials in the same condition.

NCT07243782 — Regulatory Post-Marketing Surveillance in Hidradenitis Suppurativa, Pediatric Plaque Psoriasis and JIA Treated With Cose · recruiting
NCT05879419 — Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases · Phase 4 · active not recruiting
NCT06007456 — Clinical, Laboratory and Ultrasound Stratification of Patients With Juvenile Idiopathic Arthritis · recruiting
NCT03913962 — Health and Exercise Response in Children With Chronic and Auto-immune Pathologies · NA · recruiting
NCT06560606 — UCAN CAN-DU: Canada-Netherlands Personalized Medicine Network in Childhood Arthritis and Rheumatic Disease · recruiting

Other University of Genova trials

Trials by the same sponsor.

NCT07351435 — The Caribbean Registry of Extracorporeal Membrane Oxygenation (ECMO) From the University Hospital in Martinique · not yet recruiting
NCT06689020 — Positive Expiratory Pressure (PEP) and Continuous High-frequency Oscillation (CHFO) on Lung RECRUITment Using Electrical · not yet recruiting
NCT06367816 — Brain Recovery With Automated VEntilation · completed
NCT05135962 — Maxillary Expansion: Leaf Expander Versus Hyrax Expander · NA · unknown
NCT05748704 — Metabolic and Immunological Effects of a Modified Fasting Regimen in Cancer Patients · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05467579 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Genova
Last refreshed: 20 July 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05467579.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing